Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' DEFICIT (Tables)

v3.23.1
STOCKHOLDERS' DEFICIT (Tables)
3 Months Ended
Mar. 31, 2023
Summary of outstanding warrants

A summary of outstanding warrants as of March 31, 2023 and December 31, 2022 is presented below:

 

 

 

March 31, 2023

 

 

December 31, 2022

 

 

 

Number of
Warrants

 

 

Weighted‑
Average
Exercise
Price

 

 

Number of
Warrants

 

 

Weighted‑
Average
Exercise
Price

 

Warrants outstanding, beginning of period

 

 

6,610,520

 

 

$

2.22

 

 

 

8,236,017

 

 

$

5.78

 

Granted

 

 

8,500,000

 

 

 

4.03

 

 

 

500,000

 

 

 

2.50

 

Exercised

 

 

 

 

 

 

 

 

 

 

 

 

Cancelled, forfeited or expired

 

 

(174,999

)

 

 

14.04

 

 

 

(2,125,497

)

 

 

14.38

 

Warrants outstanding, end of period

 

 

14,935,521

 

 

$

3.09

 

 

 

6,610,520

 

 

$

2.22

 

Warrants exercisable end of period

 

 

14,935,521

 

 

$

3.09

 

 

 

6,610,520

 

 

$

2.22

 

Summary of stock option activity

A summary of outstanding stock options as of March 31, 2023 and December 31, 2022 is presented below.

 

 

 

March 31, 2023

 

 

December 31, 2022

 

 

 

Number of
Options

 

 

Weighted‑
Average
Exercise
Price

 

 

Number of
Options

 

 

Weighted‑
Average
Exercise
Price

 

Options outstanding, beginning of period

 

 

4,660,787

 

 

$

5.08

 

 

 

5,968,338

 

 

$

4.78

 

Granted or deemed granted

 

 

1,250,000

 

 

$

4.50

 

 

 

 

 

$

 

Exercised

 

 

 

 

$

 

 

 

 

 

$

 

Cancelled, forfeited and expired

 

 

(2,364,447

)

 

$

3.46

 

 

 

(1,307,551

)

 

$

3.73

 

Options outstanding, end of period

 

 

3,546,340

 

 

$

5.95

 

 

 

4,660,787

 

 

$

5.08

 

Options exercisable, end of period

 

 

2,493,840

 

 

$

6.57

 

 

 

4,645,286

 

 

$

5.10

 

Options available for future grant

 

 

2,750,000

 

 

 

 

 

 

4,000,000

 

 

 

 

S T I P2021 Plan [Member]  
Schedule of fair value of conversion feature liabilities The following table presents the assumptions used on the recent dates on which options were granted by the Company. The risk‑free interest rate is based on the implied yield available on U.S. Treasury issues with a term approximating the expected life of the options depending on the date of the grant and expected life of the respective options.

 

 

 

January 12, 2023

 

Stock Price

 

$

0.31

 

Exercise Price

 

$

4.50

 

Expected term

 

5-6 years

 

Risk-Free Rate

 

3.51-3.53%

 

Dividend Yield

 

 

Volatility

 

108.16-116.40%

 

Convertible Promissory Note [Member]  
Schedule of fair value of conversion feature liabilities

The following table presents the assumptions used to value the most recent warrants granted by the Company.

 

 

January 2023

Stock price

 

$0.31 - $0.49

Exercise price

 

$0.47 - $4.50

Expected term

 

5 years

Risk-free rate

 

3.53%-3.66%

Dividend yield

 

Volatility

 

116.40% - 119.14%